Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
500.00    -2.00 (-0.40%)
Bid:
500.00
Ask:
506.00
Spread: 6.00 (1.20%)
Market Cap: £823.83m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director/PDMR Shareholding

26 Jun 2012 07:00

RNS Number : 1104G
Oakley Capital Investments Limited
26 June 2012
 



26 June 2012

 

 

 

Oakley Capital Investments Limited

 

 

Director's Dealings

 

Oakley Capital Investments Limited ("the Company") was notified on 22 June 2012 by Laurence Blackall, a non-executive director of the Company, that a pension fund to which he is the sole beneficiary purchased 200,000 ordinary shares of 1 pence each ("Ordinary Shares") on 22 June 2012 at a price of 118p pence per share. Following this transaction, Mr Blackall has a beneficial interest in 200,000 Ordinary Shares, representing approximately 0.2% of the total voting rights of the Company.

 

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens (Director)

 

FTI Consulting

+44 20 7831 3113

Ed Bridges

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Steven Tredget

 

 

 

About Oakley Capital Investments Limited

 

The Company was established to provide investors with access to the investment strategy being pursued by the Limited Partnership.

 

The primary objective of the Limited Partnership is to invest in a diverse portfolio of private mid-market UK and European businesses, aiming to provide investors with significant long-term capital appreciation.

 

The investment strategy of the Limited Partnership is to focus on companies with the scope for performance improvement operating within industries with growth or consolidation potential. In addition, the Limited Partnership seeks to invest in companies with the potential to achieve scale, thereby commanding a premium on exit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQELFLLQFXBBK
Date   Source Headline
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.